InvestorsHub Logo
icon url

akasidney86

04/29/15 3:57 AM

#1749 RE: Viperciara #1748

Yes, Viper, but of course that's a double edged sword because it takes so long. However, as your other link states and as can be read in much recent literature and MB postings, median OS or other traditional, shorter oncologic endpoints just may not work too well given the MOA of immunologic treatments.

Many thanks for all your postings.